Summit Therapeutics Discusses It’s Multiple DMD Partnerships

Glyn Edwards of Summit Therapeutics discusses his company’s partnerships with the Duchenne muscular dystrophy (DMD) community and with Sarepta Therapeutics. DMD is one of the most common, fatal genetic disorders diagnosed in children around the world. DMD is an...

Being Diagnosed with Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people in the United States. The disease is named for the three physicians who first identified it in 1886 – Jean-Martin Charcot and...

Thijs Spoor of AzurRx Provides an Overview of Cystic Fibrosis

Thijs Spoor of AzurRx Provides an Overview of Cystic Fibrosis Cystic fibrosis (CF) is a life-threatening genetic disease that primarily affects the lungs and digestive system. An estimated 30,000 children and adults in the United States (70,000 worldwide) have CF. In...

The Importance of Advocacy Groups Such as the Fragile X Foundation

Dr. Daniel Alkon of Neurotrope BioSciences discusses the importance of partnering with Advocacy Groups such as the Fragile X Foundation for company. Neurotrope has reached out to advocacy groups for their clinical trial strategy for Bryostatin 1 for the treatment of...
  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.